[AMRS] Amyris, Inc.

Overview

Type of security: Stock

Sector: Basic Industries

Industry: Major Chemicals

Market Capitalization: 84.47 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.71 Change: 0.03 (4.28%)
Ext. hours: 0.7 Change: -0.01 (-1.22%)

chart AMRS

Refresh chart

Strongest Trends Summary For AMRS

AMRS is in the medium-term down -53% in 4 months. In the long-term down -100% below S&P in 11 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Amyris, Inc., a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. It builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The company produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the production and commercialization of diesel and jet fuels. The company was former

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding211.17 M EPS-6.31 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -15.42% Sales Growth - Q/Q-32.05% P/E-0.48
P/E To EPS Growth P/S1.87 P/BV-0.46 Price/Cash Per Share1.86
Price/Free Cash Flow-0.94 ROA-34.92% ROE36.34% ROI-54.44%
Current Ratio1.34 Quick Ratio1.12 Long Term Debt/Equity17.06 Debt Ratio-0.28
Gross Margin21.8% Operating Margin-217.94% Net Profit Margin-149.48% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities7.32 M Cash From Investing Activities-1.07 M Cash From Operating Activities-3.28 M Gross Profit1.23 M
Net Profit-52.24 M Operating Profit-25.16 M Total Assets193.05 M Total Current Assets69.3 M
Total Current Liabilities51.65 M Total Debt242.99 M Total Liabilities378.61 M Total Revenue7.87 M
Technical Data
High 52 week9.2 Low 52 week3.02 Last close4.04 Last change0.75%
RSI56.07 Average true range0.37 Beta1.21 Volume768.67 K
Simple moving average 20 days7.78% Simple moving average 50 days-15.27% Simple moving average 200 days-35.91%
Performance Data
Performance Week6.88% Performance Month-6.91% Performance Quart-53.19% Performance Half-39.06%
Performance Year-4.27% Performance Year-to-date20.96% Volatility daily5.49% Volatility weekly12.28%
Volatility monthly25.17% Volatility yearly87.2% Relative Volume154.97% Average Volume1.36 M
New High New Low

News

2019-01-19 17:58:00 | Amyris Has Big Growth Plans Again. It Will Likely Fail to Meet Them Again

2018-12-31 08:30:00 | Amyris Announces Signing of Nutritional Product Royalty Agreement

2018-12-23 03:44:26 | Hedge Funds Are Crazy About Amyris Inc AMRS

2018-12-20 08:58:13 | Phil Hempleman’s Ardsley Partners’ Returns, AUM and Holdings

2018-12-12 08:30:00 | Amyris Receives GRAS Notification from FDA for its New, Sugarcane-Derived, Zero Calorie Sweetener

2018-12-11 17:13:33 | Amyris Closes on Debt Solution

2018-12-10 16:13:36 | Health Care Digest: Where were the women in Gilead's CEO search — and more

2018-12-10 08:30:00 | Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand

2018-12-07 08:36:55 | Amyris Takes Major Step Forward in Addressing its Convertible Debt

2018-12-04 08:30:00 | Amyris Celebrates Launch of New Zero Calorie, Naturally-Derived Sweetener

2018-12-03 12:25:19 | Company behind Chanel perfume gets into sweetener business

2018-12-03 09:43:47 | Once a cleantech darling, this East Bay company looks to pour it on with syn-bio sweetener

2018-12-03 08:46:22 | U.S. and China set to finalize a trade deal in the next three months

2018-12-03 07:00:00 | Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers

2018-11-30 08:57:32 | Amyris Partners with Givaudan to Introduce a Tabletop Application for its Zero Calorie, Naturally Sourced Sweetener

2018-11-16 12:25:00 | Here's Why Amyris Can't Stop Sliding This Week

2018-11-14 11:17:00 | Here's Why Amyris Is Getting Obliterated Today

2018-11-14 03:54:39 | Edited Transcript of AMRS earnings conference call or presentation 13-Nov-18 9:30pm GMT

2018-11-13 16:01:40 | Amyris Reports Third Quarter 2018 Financial Results

2018-11-13 08:17:11 | Amyris Q3 Earnings Outlook

2018-11-08 14:51:42 | Amyris Inc NASDAQ:AMRS: Is Breakeven Near?

2018-11-08 08:30:00 | Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd.

2018-11-06 10:30:03 | Amyris AMRS May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2018-10-30 08:30:00 | Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018

2018-10-23 08:30:00 | Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development

2018-10-19 08:30:00 | Amyris Successfully Producing its New Zero Calorie Natural Sweetener at Industrial Scale

2018-10-06 08:35:00 | Better Synthetic Biology Stock: Amyris vs. Codexis

2018-10-03 08:00:00 | Amyris Signs First Major Supply and Distribution Agreement for its New, Zero Calorie Sweetener with ASR Group, the World’s Largest Cane Sugar Refiner

2018-09-27 08:30:00 | Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.

2018-09-25 08:30:00 | Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 4, 2018

2018-09-17 08:30:00 | Amyris Provides Update on Leland, NC Production Facility

2018-09-12 08:30:00 | Amyris to Host Launch of its New Zero Calorie Natural Sweetener in New York on December 3, 2018

2018-08-30 11:20:00 | Salesforce Remains a 'Go to' Name for Big Cap Momentum Players

2018-08-30 09:30:00 | Amyris to Present at Rodman & Renshaw 20th Annual Global Investment Conference on September 5, 2018

2018-08-30 08:30:00 | Amyris Gets Green Light for Commercial Sales of its New, Natural, Zero-Calorie Sweetener

2018-08-21 16:30:36 | Amyris Announces Successful Closing of Secondary Offering

2018-08-20 09:42:00 | This Synthetic Biology Stock Is Soaring, but Investors Shouldn't Overlook a Key Risk

2018-08-17 11:52:00 | Here's Why Amyris Fell More Than 13% Today

2018-08-17 08:59:57 | Amyris Announces Pricing of Secondary Offering

2018-08-16 23:45:31 | Edited Transcript of AMRS earnings conference call or presentation 6-Aug-18 8:30pm GMT

2018-08-16 18:11:40 | Amyris Announces Launch of Secondary Offering by Certain Selling Stockholders

2018-08-06 16:13:58 | Amyris Delivers Another Quarter of Profitable Growth while Executing well on Strategic Agenda

2018-08-06 14:30:00 | Amyris, Inc. to Host Earnings Call

2018-08-02 08:30:00 | Amyris to Participate in Jefferies 2018 Global Industrials Conference

2018-07-30 08:30:00 | Amyris BIOSSANCE Brand Executes Significant Expansion with Agreement to Launch Across all 668 Sephora Inside JCPenney Stores

2018-07-16 09:00:00 | Amyris’s Biossance Brand leads in Clean Beauty with another record quarter; Expands capability and expertise to accelerate growth

2018-07-11 07:35:00 | Free Technical Research on Axalta Coating Systems and Three More Specialty Chemicals Equities

2018-07-02 08:30:00 | Amyris Announces Non-Dilutive $36 Million Term Loan to Pay Off Stegodon and Other Short-Term Debt Maturities

2018-06-27 08:30:00 | Amyris Expands Production Contract with ADL BioPharma Due to Demand Growth

2018-06-26 08:30:00 | Amyris and BGI Agree to Joint Venture to Develop Products to Improve Human Health in Greater China